PRB3 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:5544, G1, HGNC:9339, MIM:168840, NM_006249, NP_006240, PRB3, PRG, proline rich protein BstNI subfamily 3

Omim:OMIM:168840

Id:ENSG00000197870

Hgnc:HGNC:9339

Entrez:5544

Ensembl:ENSG00000197870

Description:proline rich protein BstNI subfamily 3

This gene encodes a member of the heterogeneous family of basic, proline-rich, human salivary glycoproteins. Multiple alleles of this gene exhibiting variations in the length of the tandem repeats have been identified. The reference genome encodes the "Long" allele. The protein isoforms encoded by this gene are recognized as the "first line of oral defense" against the detrimental effects of polyphenols in the diet and pathogen infections. This gene is located in a cluster of closely related salivary proline-rich proteins on chromosome 12. [provided by RefSeq, Nov 2015]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PRB3's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PRB3.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PRB3.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PRB3.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PRB3.

Results found

Linked to

	Label	Description
	GSE151083 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139178 GDC-0068 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135030 3 V 1 FLUDARABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE151083 0 V 1 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 neratinib OVCAR-8 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 11 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 0 V 1 MENADIONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE151083 enzalutamide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE139178 GDC-0068 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE135030 3 V 1 FLUDARABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE261563 CX-5461 3 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE151083 0 V 1 ENZALUTAMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE128730 neratinib OVCAR-8 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 7 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE139540 menadione 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 11 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE139540 0 V 1 MENADIONE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.